Stockscreener 앱 받기
2.015
7.75%
0.145
시간 외 거래:
2.06
0.045
+2.23%
전일 마감가:
$1.87
열려 있는:
$1.87
하루 거래량:
59,627
Relative Volume:
0.90
시가총액:
$47.71M
수익:
$12.00M
순이익/손실:
$-63.23M
주가수익비율:
-0.256
EPS:
-7.87
순현금흐름:
$-43.02M
1주 성능:
+8.92%
1개월 성능:
+3.33%
6개월 성능:
+117.88%
1년 성능:
-65.61%
1일 변동 폭
$1.87
$2.02
1주일 범위
$1.80
$2.02
52주 변동 폭
$0.73
$6.20
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
명칭
Accelerate Diagnostics Inc
전화
303-863-8088
주소
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-09 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-10-08 | 개시 | BTIG Research | Neutral |
| 2020-08-07 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-09-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-11-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-05-24 | 개시 | Craig Hallum | Hold |
| 2017-12-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-07-12 | 재개 | BTIG Research | Buy |
| 2016-03-24 | 개시 | JP Morgan | Overweight |
| 2015-12-16 | 개시 | Piper Jaffray | Overweight |
모두보기
Accelerate Diagnostics Inc 주식(AXDX)의 최신 뉴스
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies - PR Newswire
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
AXDXAccelerate Diagnostics, Inc. Latest Stock News & Market Updates - StockTitan
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - StockTitan
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Comparing Accelerate Diagnostics (NASDAQ:AXDX) & Advanced BioMedical Technologies (OTCMKTS:ABMT) - Defense World
Antimicrobial Resistance Diagnostics Market to Witness an Outstanding Growth by 2032 - openPR
Antibiotic Sensitivity Testing Market Growth and Industry Overview - News in Assen
Accelerate Diagnostics (NASDAQ:AXDX) Research Coverage Started at StockNews.com - Defense World
Optical Imaging Market Size to Reach USD 5.61 Billion by 2033 | Straits Research - GlobeNewswire
Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution - PR Newswire
Saudi Arabia Diagnostic Imaging Market Will Accelerate Rapidly - openPR
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System - Yahoo Finance
FDA approves Accelerate Arc system to identify microbial infections - Medical Device Network
FDA clears new system for rapid sepsis identification By Investing.com - Investing.com Australia
FDA clears new system for rapid sepsis identification - Investing.com
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - StockTitan
Short Interest in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Drops By 12.6% - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Stake Reduced by Armistice Capital LLC - Defense World
StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Italy Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
North America Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
PersonalAIze and Cube Forge Groundbreaking Partnership to - GlobeNewswire
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics - Yahoo Finance
Accelerate Diagnostics (NASDAQ:AXDX) Stock Crosses Above 200 Day Moving Average of $1.21 - Defense World
Veterinary Antimicrobial Susceptibility Testing Market: In-depth Analysis Of Market Trends, Technological A... - WhaTech
Blood Screening Market Advancements Highlighted by Size, Share, Growth Analysis, Business Insights And Fore... - WhaTech
North America Antibiotic Sensitivity Testing Market By Application - Third Eye News
RenovaroCube to Present Cutting-Edge Cancer Diagnostics - GlobeNewswire
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine - Business Wire
Chlamydia Infection Diagnostics And Therapeutics Global Market 2024Latest Trends, Technological Advancem... - WhaTech
Blood Culture Tests Market 2024: Pioneering Innovations in Diagnostic Healthcare As Discussed In New Market... - WhaTech Technology and Markets News
New Release of Ibex Medical Analytics AI-powered Platform to Accelerate Advancements in Cancer Diagnostics - Business Wire
India Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
In Vitro Diagnostics Market Trends 2024-2033: Overview, Share, Demand, and Outlook - WhaTech
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Emerging Trends and Opportunities in the Antimicrobial Susceptibility Testing Market - openPR
Accelerate Diagnostics regains Nasdaq compliance - Investing.com
Sepsis Diagnostics Market to Surge at 8.5% CAGR Through 2032Market.us Media - Market.us Media - United States Market News
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results - Longview News-Journal
Accelerate Diagnostics Inc [AXDX] Insider Mertz Larry Michael sells 361 Shares - Knox Daily
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial - Yahoo Finance Australia
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns - Yahoo Finance
Latin America Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
Earnings call: Accelerate Diagnostics Q2 2024 results and Wave program update - Investing.com
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q2 2024 Earnings Call Transcript - Insider Monkey
Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha
Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results - Kilgore News Herald
AXDX Stock Earnings: Accelerate Diagnostics Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
Accelerate Diagnostics: Q2 Earnings Snapshot - CTPost
Accelerate Diagnostics Inc (AXDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Accelerate Diagnostics Inc 주식 (AXDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FRANCESCONI LOUISE | Director |
Jun 28 '24 |
Option Exercise |
0.00 |
4,737 |
0 |
33,558 |
| SCHULER JACK W | Director |
Jun 28 '24 |
Option Exercise |
0.00 |
4,737 |
0 |
20,225 |
| BURRIS WAYNE | Director |
May 31 '24 |
Option Exercise |
0.00 |
839 |
0 |
1,678 |
| FRANCESCONI LOUISE | Director |
May 29 '24 |
Option Exercise |
0.00 |
7,894 |
0 |
28,821 |
| Regan Jennifer | Director |
May 29 '24 |
Option Exercise |
0.00 |
12,631 |
0 |
12,631 |
| SCHULER JACK W | Director |
May 29 '24 |
Option Exercise |
0.00 |
7,894 |
0 |
15,488 |
| MASSARANY HANY | Director |
May 29 '24 |
Option Exercise |
0.00 |
7,894 |
0 |
32,154 |
| Mertz Larry Michael | Chief Technology Officer |
May 20 '24 |
Option Exercise |
0.00 |
1,283 |
0 |
82,114 |
| Mertz Larry Michael | Chief Technology Officer |
May 20 '24 |
Sale |
0.88 |
361 |
318 |
81,831 |
| Phillips Jack | Chief Executive Officer |
Apr 17 '24 |
Option Exercise |
0.00 |
59,928 |
0 |
189,654 |
0.47%
1.00%
자본화:
|
볼륨(24시간):